Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys
about
Lower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primatesNonhuman primate positron emission tomography neuroimaging in drug abuse researchDopamine transporter-related effects of modafinil in rhesus monkeys.Influence of chronic dopamine transporter inhibition by RTI-336 on motor behavior, sleep, and hormone levels in rhesus monkeysNeuroimaging and drug taking in primatesIn vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the ratDual dopamine/serotonin releasers: potential treatment agents for stimulant addictionBehavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkeyBehavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterNonhuman primate neuroimaging and cocaine medication developmentPET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.Monoamine transporter inhibitors and substrates as treatments for stimulant abuseIndividual differences and social influences on the neurobehavioral pharmacology of abused drugs.meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseBrain imaging in nonhuman primates: insights into drug addiction.Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.Cocaine-induced reinstatement during limited and extended drug access conditions in rhesus monkeys.Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, metRelationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeysSynthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.Preclinical evaluation of the abuse potential of the analgesic bicifadine.Further structure-activity relationship studies on 8-substituted-3-[2-(diarylmethoxyethylidenyl)]-8-azabicyclo[3.2.1]octane derivatives at monoamine transporters.Behavioral and neurochemical effects of cocaine and diphenhydramine combinations in rhesus monkeys.Agonist replacement therapy for cocaine dependence: a translational review.Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.Novel C-1 substituted cocaine analogs unlike cocaine or benztropine.Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology.Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.Identifying the molecular basis of inhibitory control deficits in addictions: neuroimaging in non-human primates.Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitorsHypothesis-driven medication discovery for the treatment of psychostimulant addictionNonhuman primate models of addiction and PET imaging: dopamine system dysregulation.Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes.Simultaneous measurement of extracellular dopamine and dopamine transporter occupancy by cocaine analogs in squirrel monkeys.Triple monoamine uptake inhibitors demonstrate a pharmacologic association between excessive drinking and impulsivity in high-alcohol-preferring (HAP) mice.2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter.
P2860
Q24605771-2FD814E0-16E8-48AC-AEED-205105A1343BQ24607038-0782E188-1072-4991-9FD2-A10A0980D591Q24608414-B2B910E1-94D7-468A-AA23-1722542CF4ACQ24616981-F1A9F48F-D683-4EE8-9042-214B500DB629Q24631230-4BC7C658-FE27-4B98-82F5-1C2365971A6AQ24632527-5B9F7179-13B1-4FA7-9250-02260A274EAFQ24641896-EB6F4811-BAC9-405E-8099-9D9FEE42F52BQ24651855-8A41DE8C-D705-45AB-A6C7-71491F8ECD72Q26829749-D3517D02-E399-4974-8F9D-AD6CC2CAD272Q28304167-00C637E5-242B-44B2-B992-B07310342645Q30403978-2A22D929-57C9-4C2A-AAFA-28058A53002EQ30413718-E140A4E4-DE39-4F2D-9696-1B7FA8AE76DFQ30445210-EBBF3E94-2DD1-46D8-A133-C93F0EA5738FQ30498938-EB46EA1F-CDBF-4620-B8BF-6A864B6CC9CDQ31141730-D28D3ADA-588D-4033-9092-F50559E99B2DQ33383360-7B54938E-E36C-4F68-9E4D-26ECAE8F8307Q33552551-76000128-8632-46CA-8983-E6DAC583443AQ33738377-67706E95-99BC-4C24-B74E-AF44CDF5C1CAQ33998159-AD3700FB-A867-4B06-86D3-A2A568CC648AQ34202539-C9342A97-E84B-4B4D-982C-85456B2368A4Q34768278-216A82B2-9B65-446F-92D7-20081DE71E3BQ34777680-5A924305-1CC5-449F-A90D-69FCB0A2EB1DQ34986560-5AD8A412-E75D-4015-B69C-72DD90BCE4DDQ35453895-9E5360FC-05B8-49D0-9F32-9DEE4AB30240Q35590737-2D1AF1A3-7DAF-4E04-8665-31D276B94493Q35599708-0A2C2014-C91C-499B-9A09-A7CBB6A7D18EQ35799846-95C6AF69-F069-4792-8F73-3294F4590C55Q36312733-48202B56-7490-4CEC-9C7F-85E297674341Q36335545-DDD4175E-87DD-4768-B662-0A79DB44BF22Q36511165-AD009CFC-60C5-495A-ACD9-E8630776C4ECQ36709254-AFD79443-7D51-4BFB-AEBF-B71BB5DE9472Q37062538-24518783-EF70-4CB2-A5B3-97981C69C8FCQ37064229-EE8D769E-C82A-49A9-893E-3D744C7E07E2Q37168501-85F08394-BD17-401F-B155-5420AA51AFA4Q37183687-43287336-EA14-4725-8DB3-F0163529EFADQ37317268-6DCC8A68-7BFD-49B2-ACDB-5A09F15BF197Q37460264-EA9C9311-1A63-4871-AD0B-793480CEE025Q37632839-A3C684B1-6F2F-42B9-A746-3B43A1DEF026Q37700079-F9279B31-6FA7-4065-A2A6-F9DA911CCC56Q37707743-80D8BD91-5DAF-4CDB-AE7E-BC181BCB31CE
P2860
Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Effects of combined dopamine a ...... ministration in rhesus monkeys
@ast
Effects of combined dopamine a ...... ministration in rhesus monkeys
@en
Effects of combined dopamine a ...... ministration in rhesus monkeys
@nl
type
label
Effects of combined dopamine a ...... ministration in rhesus monkeys
@ast
Effects of combined dopamine a ...... ministration in rhesus monkeys
@en
Effects of combined dopamine a ...... ministration in rhesus monkeys
@nl
prefLabel
Effects of combined dopamine a ...... ministration in rhesus monkeys
@ast
Effects of combined dopamine a ...... ministration in rhesus monkeys
@en
Effects of combined dopamine a ...... ministration in rhesus monkeys
@nl
P2093
P921
P356
P1476
Effects of combined dopamine a ...... ministration in rhesus monkeys
@en
P2093
F Ivy Carroll
Heather L Kimmel
John R Votaw
Leonard L Howell
Mark M Goodman
P304
P356
10.1124/JPET.106.108324
P407
P577
2007-02-01T00:00:00Z